On July 4, 2019, Anhui Healkkang Pharmaceutical and Beijing Healkkang Pharmaceutical pilot test base of a new generation of antibiotic API was held in Anqing life science and technology park. Pharzen Science and Technology 's manager and the head of engineering department, Anhui Healkkang Pharmaceutical and Beijing Healkkang Pharmaceutical 's general manager and head of the project attended the commencement ceremony.

Liu peng, general manager of Pharzen Science , says that this antibiotic API project with a total investment of 8 million yuan, is a very good project with forward-looking, technical and intellectual property autonomy. The project covers an area of about 2000 square meters, with a construction area of 2500 square meters, including reaction room, crystal room, administrative office area, storage and transportation facilities. Anhui Healkkang Pharmaceutical and Beijing Healkkang Pharmaceutical's new generation of antibiotic API pilot test base will create a large number of high-quality new generation of antibiotic API, making the new generation of antibiotics to market, to the country, to the international..

According to introducing, the new generation antibiotics API experimental base for experimental research and development projects, with the main research  of antibiotics API probenecid sodium. It guarantees the material balance technique, the influence on the regional ecological environment is very mild, in line with the national industrial policy, project site conform to the requirements of the planning. It is in China's high-tech enterprises of science and technology research projects, and will also drive the demonstration role for enterprises to the park.